WELL Health Technologies Corp. (TSE:WELL) Receives C$7.13 Average Price Target from Analysts

WELL Health Technologies Corp. (TSE:WELL) has received an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is C$7.13.

Separately, Stifel Nicolaus reduced their target price on WELL Health Technologies from C$11.00 to C$10.00 in a research report on Monday, April 29th.

WELL Health Technologies Trading Up 0.9 %

Shares of TSE:WELL opened at C$4.71 on Friday. The company has a market capitalization of C$1.16 billion, a PE ratio of 39.25, a P/E/G ratio of -1.93 and a beta of 1.24. The company has a current ratio of 1.48, a quick ratio of 1.02 and a debt-to-equity ratio of 48.62. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$4.93. The business’s fifty day simple moving average is C$3.91 and its 200-day simple moving average is C$3.86.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.